Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002551 · ClinicalTrials.gov registry record · Phase 3
SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed
A Phase 3 study, sponsored by SWOG Cancer Research Network.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,917
- Enrollment target
NCT00002551: Completed Phase 3 study, sponsored by SWOG Cancer Research Network.
NCT00002551 is a Phase 3 study that has completed, run by SWOG Cancer Research Network. The registered enrollment target is 1,917 participants, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (148% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002551, a Phase 3 study, has completed, sponsored by SWOG Cancer Research Network.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,917 participants
- Enrollment target
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which treatment regimen is more effective for rectal cancer. PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy plus radiation therapy in treating patients who have rectal cancer that has been surgically removed.
Interventions
- DRUG fluorouracil
- DRUG leucovorin calcium
- RADIATION radiation therapy
- DRUG levamisole hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,917 participants |
| Start Date | 1994-03 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
What the finished NCT00002551 record still lists
NCT00002551 is an interventional study that assigns participants to a tested intervention. Its 1,917 participants enrollment target places it among the larger protocols in the corpus, above the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (148% higher).
The record links to 0 conditions, and to 4 interventions - of which fluorouracil is the first listed.
NCT00002551 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002551 about?
NCT00002551 is a clinical study titled "SWOG-9304 Chemotherapy Plus Radiation Therapy in Treating Patients With Rectal Cancer That Has Been Surgically Removed". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Radiation therapy uses high-energy x-rays to damage tumor cells. It is not yet known which treatment regimen is more effective for rectal cancer. PURPOSE: Randomized phase III tri...
What is the current status of trial NCT00002551?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,917 participants. The study started on 1994-03. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00002551?
The interventions under investigation include: fluorouracil (DRUG), leucovorin calcium (DRUG), radiation therapy (RADIATION), levamisole hydrochloride (DRUG).
Who is sponsoring clinical trial NCT00002551?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00002551's enrollment target sits among peer trials
1,917 109th of 2000 higher than 1,892 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06058455 · 1,920 participants · NA
An Evaluation of an Online Sexual Assault Resistance Program (IDEA3)
- NCT05174169 · 1,912 participants · Phase 2
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- NCT06799117 · 1,912 participants · NA
Adaptive Decision Support for Addiction Treatment Master
- NCT05233150 · 1,932 participants · NA
Child-Adult Relationship Enhancement in Primary Care (PriCARE) / Criando Niños Con CARIÑO (CARIÑO)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia